ZGPAT
Gene Information
- Official Symbol: ZGPAT
- Official Name: zinc finger CCCH-type and G-patch domain containing
- Aliases and Previous Symbols: N/A
- Entrez ID: 84619
- UniProt: Q8N5A5
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
| G-patch |
GO Terms
| negative regulation of epidermal growth factor-activated receptor activity |
| regulation of epidermal growth factor-activated receptor activity |
| negative regulation of protein tyrosine kinase activity |
| negative regulation of epidermal growth factor receptor signaling pathway |
| negative regulation of ERBB signaling pathway |
| negative regulation of peptidyl-tyrosine phosphorylation |
| negative regulation of signaling receptor activity |
| regulation of epidermal growth factor receptor signaling pathway |
| regulation of protein tyrosine kinase activity |
| regulation of ERBB signaling pathway |
| regulation of signaling receptor activity |
| negative regulation of protein kinase activity |
| DNA-binding transcription repressor activity, RNA polymerase II-specific |
| negative regulation of kinase activity |
| regulation of peptidyl-tyrosine phosphorylation |
| negative regulation of transferase activity |
| negative regulation of protein phosphorylation |
| sequence-specific DNA binding |
| negative regulation of phosphorylation |
| RNA polymerase II proximal promoter sequence-specific DNA binding |
| negative regulation of phosphate metabolic process |
| negative regulation of phosphorus metabolic process |
| negative regulation of protein modification process |
| DNA-binding transcription factor activity |
| negative regulation of catalytic activity |
| regulation of protein kinase activity |
| negative regulation of transcription by RNA polymerase II |
| regulation of kinase activity |
| regulation of transferase activity |
| negative regulation of cellular protein metabolic process |
| negative regulation of protein metabolic process |
| negative regulation of molecular function |
| negative regulation of transcription, DNA-templated |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| negative regulation of signal transduction |
| negative regulation of RNA metabolic process |
| negative regulation of cell communication |
| negative regulation of signaling |
| negative regulation of cellular macromolecule biosynthetic process |
| negative regulation of nucleobase-containing compound metabolic process |
| regulation of protein phosphorylation |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| negative regulation of biosynthetic process |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of phosphorylation |
| negative regulation of response to stimulus |
| negative regulation of gene expression |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of protein modification process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
No hits were found.
Most Correlated Genes in Chemogenomics
No correlation found to any other genes in chemogenomics.
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 3570
- Expression level (log2 read counts): 5.03
Expression Distribution
ZGPAT Expression in NALM6 Cells: 5.03
